Safety of single-dose nevirapine for prevention of vertical transmission of human immunodeficiency virus infection

Indian Journal of Pharmacology

Volumn 43, Issue 2, 2011, Pages 207-209

  Murthy, Mangala ^a   Krishnamurthy, Bhaskar ^a  

^a Government Medical College   (India)

Author keywords

Nevirapine; prevention of mother to child transmission of HIV; vertical transmission

Indexed keywords

NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; DRUG SAFETY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAUNDICE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NAUSEA; NEWBORN; PREGNANCY; PUERPERIUM; RASH; SINGLE DRUG DOSE; STEVENS JOHNSON SYNDROME; VERTICAL TRANSMISSION; VOMITING;

EID: 79957563060     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.77372     Document Type: Article

References (10)

1. Surjushe A, Maniar J. Prevention of mother-to-child transmission. Indian J Dermatol Venereol Leprol 2008;74:200-7. (Pubitemid 351918870)
2. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 2003;362:859-68. (Pubitemid 37130095)
3. Prevention of Parent To Child Transmission (PPTCT). National AIDS control Organization. Available from: http://www.nacoonline.org/National-AIDS-Control- Program/Services-for-Prevention/PPTCT/ [last cited in 2010].
4. Suksomboon N, Poolsup N, Ket-Aim S. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. J Clin Pharm Ther 2007;32:293-311. (Pubitemid 46699523)
5. Stringer JS, Sinkala M, Chapman V, Acosta EP, Aldrovandi GM, Mudenda V, et al. Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS 2003;17:1659-65. (Pubitemid 36951686)
6. McIntyre JA. Controversies in the use of nevirapine for prevention of mother-tochild transmission of HIV. Expert Opin Pharmacother 2006;7:677-85.
7. Taiwo BO. Nevirapine toxicity. Int J STD AIDS 2006;17:364-70. (Pubitemid 43765395)
8. Joy S, Poi M, Hughes L, Brady MT, Koletar SL, Para MF, et al. Third-trimester maternal toxicity with nevirapine use in pregnancy. Obstet Gynecol 2005;106:1032-8. (Pubitemid 41532910)
9. Lyons F, Hopkins S, Kelleher B, McGeary A, Sheehan G, Geoghegan J, et al. Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy. HIV Med 2006;7:255-60.
10. Lockman S, Shapiro RL, Smeaton LM, Wester C, Thior I, Stevens L, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med 2007;356:135-47. (Pubitemid 46089674)